18 Aug

RADIO NEW ZEALAND NATIONAL_Valneva New Study

Exciting for PharmaSols CRO and NZ to be involved in this international COVID-19 vaccine trial. “New Zealand needs to continue to contribute to the global effort to develop Covid-19 vaccines. This study gives New Zealanders an opportunity to be involved at a personal level. The participation of older adults is critical to help evaluate new vaccines for this population." Dr Frances Priddy

https://lnkd.in/ghDhVkba

Other News

PharmaSols - HiRO announcement

PharmaSols acquired by the newly established global CRO based in Shanghai, HiRO.

Read more
The ANZ Advantage

4 reasons why biotechs need to reconsider running clinical trials in the US – the ANZ advantage

Read more
PharmaSols proud to be the NZ CRO partner on an important COVID-19 clinical trial.

PharmaSols proud to be working with Orbis Diagnostics as the NZ CRO partner on this important COVID-19 clinical trial.

Read more